Prelude Therapeutics Inc (PRLD) dividend history
PRLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 7/3067% above fair value
$3.45−0.07 (-1.99%)
Close on Nov 13, 2026Market cap $275.32MP/E –Yield –
Dividends
Prelude Therapeutics has not reported a dividend
No dividend per share appears in Prelude Therapeutics's annual filings since fiscal 2018.
See a number that looks wrong?